Toggle navigation
Home
Search
Services
Blog
Contact
About
Human Monoclonal Antibodies
Hwang, Kou M.
Genelabs Technologies, Inc., Redwood City, CA, United States
Search 5 grants from Kou Hwang
Search grants from Genelabs Technologies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Tumor-associated neutrophils in human lung cancer
Conexion: A localized information resource for a low-income Hispanic community
NO-mediated neuroprotection against alcohol: mechanism and potential therapy
Chemokine Synergy with Pdgf - Oligodendrocyte Precursors
Leucine Metabolism and Diabetes in Pregnancy - Effect of Diabetes
Recently added grants:
Metabolic interactions in the pancreatic tumor microenvironment
Retail Environment for Tobacco and Marijuana in California: Impact on College Student Use
Oral immune activation and alveolar bone loss in HIV-infected postmenopausal women
Control of Trabecular Meshwork Cytoskeleton
Neural circuitry of safety, fear and reward cue discrimination
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067938-001
Application #
3614576
Study Section
Project Start
1986-09-18
Project End
Budget Start
1986-11-01
Budget End
1987-03-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Genelabs Technologies, Inc.
Department
Type
DUNS #
City
Redwood City
State
CA
Country
United States
Zip Code
94063
Related projects
NIH 1987
N43 CM
Human Monoclonal Antibodies
Hwang, Kou M. / Genelabs Technologies, Inc.
NIH 1986
N43 CM
Human Monoclonal Antibodies
Hwang, Kou M. / Genelabs Technologies, Inc.
Comments
Be the first to comment on this grant